Xoran Technologies Secures $8M Funding to Advance Mobile CT Imaging System Research

VCBeat (WeChat ID: vcbeat) has learned that Xoran Technologies has secured a total of $8 million in funding from a matching grant program associated with the U.S. National Institutes of Health to support research on its xCAT IQ mobile CT imaging system.

In this financing round, the National Cancer Institute plans to provide Xoran with $4 million in R&D funding over the next three years through Small Business Innovation Research (SBIR) grants. Meanwhile, Decathlon Capital Partners will provide an additional $4 million in matching investment. Decathlon has agreed to allow repayment of the investment from Xoran’s future revenues, without taking any equity stake.

It is reported that Xoran plans to use the grant funds to develop an imaging system that leverages laparoscopic equipment, enables remote control of surgical instruments, and is robotically operated to achieve surgical navigation and intraoperative imaging. The development of this imaging system will reduce surgical time and improve surgical efficiency and safety.

Xoran was founded in 2001 by two research scientists from the University of Michigan, with the aim of developing innovative technologies grounded in practicality to enable physicians to treat patients more effectively. By producing high-quality, safe, and effective products that comply with industry standards and regulations, Xoran provides physicians with accurate diagnostic tools and convenient medical solutions.

Since 2001, Xoran has been a pioneer and market leader in cone-beam computed tomography (CBCT). The current Xoran Technologies product line includes Luminx DR, MiniCAT IQ, MiniCAT 2020, CAT, xCAT IQ, VetCAT, and XoranConnect® (a web-based medical image viewing and archiving tool).

The company’s recently launched xCAT IQ is a compact, mobile CT scanner capable of high-resolution cranial imaging. Featuring zero-turn-radius maneuverability, an open design, and the ability to operate on backup battery power during scans, it can be installed in confined spaces and is easy to use.

“Xoran Chief Technology Officer William van Kampen said, ‘We appreciate NCI’s support for our research and development in this exciting field, which will enable our scientists and engineers to enhance the safety of minimally invasive neurosurgical procedures and promote their widespread adoption.’”

Xoran CEO Misha Rakic stated, “The benefits for patients with stroke and traumatic brain injury cannot be overstated. By utilizing a low-dose, low-burden, flexible imaging system, patients can receive faster, more accurate, and more comfortable care. In the future, leveraging artificial intelligence (AI), we can enable early stroke detection in emergency room (ER) and telemedicine settings, thereby improving treatment outcomes and reducing hospital stays.”

The National Institutes of Health (NIH), established on January 1, 1887, is an agency within the U.S. Department of Health and Human Services. It serves as the primary U.S. government agency responsible for biomedical and health-related research. The NIH conducts its own scientific research through its Intramural Research Program (IRP) and provides funding for biomedical research to non-NIH institutions through its Extramural Research Program.

Decathlon was founded in France in 1976, primarily offering chain retail of sporting goods and support across the entire sports industry chain, with a rich portfolio of proprietary brands.

(Compiled by Jiang Ying)